Henan Caprico Biotechnologies

Caprico Biotechnologies (CBI), established in 2013, operates within the biotechnology sector, specializing in the development and provision of reagents and services for flow cytometry. The company was founded by a collective of scientists with extensive backgrounds in chemistry, immunology, and molecular biology. While maintaining a corporate office in Zhengzhou, Henan, China, the company's operational headquarters are located in Duluth, Georgia, USA.

The firm's business is centered on producing high-quality reagents to support basic science, clinical research, and diagnostic applications. Its client base includes academic research laboratories, biopharmaceutical companies, and contract research organizations (CROs). Revenue is generated through the sale of its catalog products and the provision of custom services. The company serves a global market through direct sales and international distributors.

Caprico Biotechnologies' core offerings include a wide range of products for immunophenotyping and flow cytometry analysis. This encompasses a catalog of Analytes Specific Reagents (ASR), fluorophore-conjugated antibodies, and specialized panels for applications like T-cell clonality and PNH analysis. A key service is the custom design and development of assays, such as cytotoxicity and apoptosis quantification. The company also provides custom antibody conjugation services, producing and validating antibodies for specific flow cytometry applications within its cGMP compliant and ISO 13485:2016 certified facility.

Keywords: flow cytometry reagents, immunophenotyping, antibody production, custom assay development, biotechnology, clinical research tools, diagnostic reagents, monoclonal antibodies, ASR reagents, T-cell clonality, non-human primate antibodies, cGMP manufacturing, ISO 13485, biopharmaceutical services, life sciences, molecular biology, immunology, research antibodies, custom conjugation